Home / News / Global Vendor Neutral Archives (VNA) and Picture Archiving and Communication Systems (PACS) Market to Reach Worth USD 6.4 Bn by 2022

Global Vendor Neutral Archives (VNA) and Picture Archiving and Communication Systems (PACS) Market to Reach Worth USD 6.4 Bn by 2022

According to the latest report published by Credence Research, Inc. “Vendor Neutral Archives (VNA) and Picture Archiving and Communication Systems (PACS) Market – Growth, Future Prospects and Competitive Analysis, 2016-2024,” the VNA and PACS market was valued at USD 3,744.2 Mn in 2015, and is expected to reach USD 6,387.1 Mn by 2022, expanding at a CAGR of 5.9% from 2016 to 2024.

Browse the full report Vendor Neutral Archives (VNA) and Picture Archiving and Communication Systems (PACS) Market – Growth, Future Prospects and Competitive Analysis, 2016–2024 at http://www.credenceresearch.com/report/vendor-neutral-archives-vna-and-picture-archiving-and-communication-systems-pacs-market

Market Insights

The benefits of healthcare IT is being gradually realized by medical imaging professionals. One of such solutions is PACS that allows any healthcare organization to capture, store, retrieve, transmit and manage medical images both internally and enterprise-wide. While deploying PACS, any healthcare organization needs to consider the environment in which PACS is to be installed and other electronic systems with which PACs will be integrated.

A Vendor Neutral Archive (VNA) is the latest evolution of PACS used for image archiving and provides a single, consolidated archiving platform to host files from different PACS software. Large healthcare organizations with outdated and ineffective PACS often opt to implement enterprise-wide VNA, instead of upgrading existing PACS.

Information technologies are rapidly changing and the cost of keeping up with such technological advancements are high. Thus, when healthcare systems need to decide heavy investments on PACS or VNA, they must contemplate how their needs may change in the course of time. Traditional on-premise VNA model are ideal when the platform needs to be installed at location as it allows for flexible local server control, storage, management and security.

On-premise model is highly preferred option for high-volume throughput and local exchange of massive content file such as large images or HD video, ensuring smooth image exchange and delivery without long waiting times. Hybrid VNA is the fastest progressing delivery mode in the VNA market. Through hybrid VNA, organizations can leverage their on-premise technology and take advantage of enterprise content management solutions available and running either on public or private cloud.

The increasing adoption of health information technology (HIT) is stimulating the market for PACS. Moreover, growth will be driven by significant government initiatives to encourage the digitization of healthcare systems, as well as substantial technological advancements in imaging information technology.

Browse the full report at http://www.credenceresearch.com/report/vendor-neutral-archives-vna-and-picture-archiving-and-communication-systems-pacs-market

The expansion of the PACS market to other specialties such as oncology and endoscopy will result in further applications for PACS and higher demand among providers. The global PACS market is dominated by the departmental PACS due to the factors such as need for integrated storage of standard-compliant imaging data, government initiatives favoring advanced information systems, and increased efficiency & income after adoption of PACS.

Latest Reports:

Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market By Drug Type (Eluxadoline, Alosetron, Rifaximin, Loperamide, Diphenoxylate + Atropine, Dicyclomine and Hyoscyamine, Pipeline Drug Analysis: Ibodutant, Ramosetron), Prescription (Prescribed and OTC Drugs, Prescribed Branded and Prescribed Generic Drugs) – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022

Opioid Induced Constipation (OIC) Drugs Market By Drug Type (Methylnaltrexone Bromide, Lubiprostone, Naloxegol, Naldemedine, Elobixibat, Alvimopan, Dolcanatide), By Prescription Type ( Prescribed Drugs) – Growth, Share, Opportunities & Competitive Analysis, 2016 – 2022

Global Chronic Idiopathic Constipation (CIC) Drugs Market By Drug Type (Lubiprostone, Linaclotide, Pipeline Drug Analysis: Phase 3: Plecanatide, Elobixibat, Others), Prescription Type (Prescribed, Over the Counter Drugs) – Growth, Share, Opportunities & Competitive Analysis, 2016 – 2022

About Us:

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Who we are

Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.

Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.

Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.

What we do

We serve customers at each level of their organization, in whatever limit we can be most helpful, whether as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each engagement, we collect a group with the most suitable experience and ability.

No matter the challenge, we concentrate on delivering functional and persevering results, and preparing our customers to develop and lead. We join forces with customers to place suggestions into practice. Our research specialist work straightforwardly with customers over long stretches to create workforce aptitudes, drive operational change, and apply new working strategies.

Contact:

Name: Chris Smith

Designation: Global Sales Manager

E-mail: sales@credenceresearch.com

Ph: 1-800-361-8290

Web:  Credence Research

 

Release ID: 5788

About Chris Smith

Check Also

400-400

Worldwide Survey: Contraceptives Sales Market 2016 to 2022 Size, Share, analysis,Trends and Forecast By Acute Market Reports

Report Description: Notes: Sales, means the sales volume of Contraceptives Revenue, means the sales value ...